Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 27-30 January 2025
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-27-30-january-2025
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13-16 January 2025
https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-13-16-january-2025
New EU rules for health technology assessments become effective
https://www.ema.europa.eu/en/news/new-eu-rules-health-technology-assessments-become-effective
The Pharmya team wishes you all the best for 2025!
All of us here at Pharmya wish you a prosperous New Year. May 2025 bring health, success, and fruitful collaboration. Together, let’s continue working towards patient safety and progress in pharmacovigilance.
A common EU approach to data transparency in medicine regulation
https://www.ema.europa.eu/en/news/common-eu-approach-data-transparency-medicine-regulation
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 November 2024
https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-25-28-november-2024
European regulation on clinical trials for medicinal products: The end of the transition period
https://ansm.sante.fr/actualites/reglement-europeen-relatif-aux-essais-cliniques-de-medicaments-fin-de-la-periode-de-transition